Pediatric antibiotics: Difference between revisions

(Text replacement - "8 mg" to "8mg")
No edit summary
 
(31 intermediate revisions by 5 users not shown)
Line 1: Line 1:
= Neonatal Infections=
==Neonatal Infections==
*All doses are for patients >2 kg and at least 7 days of age
*All doses are for patients >2 kg and at least 7 days of age
*Always treat for meningitis until you are sure it is not
*Always treat for meningitis until you are sure it is not


==[[Pediatric fever of uncertain source]]==
===[[Pediatric fever of uncertain source]]===
===Neonatal (0-28 days)===
===Neonatal (0-28 days)===
{{Pediatric fever antibiotics 0-28)}}
{{Pediatric fever antibiotics 0-28)}}
Line 23: Line 23:


==[[Osteomyelitis]]==
==[[Osteomyelitis]]==
Empirix treatment: Nafcillin 200mg/kg/day IV div Q6 AND Cefotaxime 150mg/kg/day IV div Q8 for >21 days.
*Empiric treatment: [[Nafcillin]] 200mg/kg/day IV div Q6 AND [[cefotaxime]] 150mg/kg/day IV div Q8 for >21 days.


==[[UTI (peds)]]==
==[[UTI (peds)]]==
*<2 weeks: Ampicillin 100mg/kg/day IV div Q6 (or Q12 if <7 days) AND Gentamicin 3 mg/kg/day IV Q24 OR Cefotaxime 150mg/kg/day IV div Q8
*<2 weeks: [[Ampicillin]] 100mg/kg/day IV div Q6 (or Q12 if <7 days) AND [[gentamicin]] 3mg/kg/day IV Q24 OR [[cefotaxime]] 150mg/kg/day IV div Q8
*2 weeks - 2 months: Ampicillin 100mg/kg/day IV div Q6 AND Cefotaxime 150mg/kg/day div Q8
*2 weeks - 2 months: [[Ampicillin]] 100mg/kg/day IV div Q6 AND [[cefotaxime]] 150mg/kg/day div Q8


==[[Neonatal conjunctivitis]]==
==[[Neonatal conjunctivitis]]==
Line 40: Line 40:
|-
|-
| rowspan="2" | Septic shock syndromes  
| rowspan="2" | Septic shock syndromes  
| Bacteremic: ''S. pneumo, N. meningitidis, Hib'' (if not immunized)  
| [[Bacteremia]]: ''[[S. pneumo]], [[N. meningitidis]], [[H. influenzae]]'' (if not immunized)  
| rowspan="1" | Replete intravascular volume, maximize delivery of oxygen to tissues. Blood cultures. [[Ceftriaxone]] 50mg/kg/day IV/IM Q24 or Cefotaxime 150mg/kg/day IV div Q8 until afebrile x24 hours.
| rowspan="1" | Replete intravascular volume, maximize delivery of oxygen to tissues. Blood cultures. [[Ceftriaxone]] 50mg/kg/day IV/IM Q24 or [[Cefotaxime]] 150mg/kg/day IV div Q8 until afebrile x24 hours.
|-
|-
| Toxic shock syndromes: ''Staphylococcal ''(less often associated with deep tissue disease), ''Streptococcal''  
| [[Toxic shock syndrome]]: ''Staphylococcal ''(less often associated with deep tissue disease), ''Streptococcal''  
| rowspan="1" |  
| rowspan="1" |  
'''Empiric therapy should include Clindamycin and ß-lactam antibiotic until etiology is isolated.'''  
'''Empiric therapy should include [[clindamycin]] and [[beta-lactam]] until etiology is isolated.'''  


'''Staphylococcal: '''Most often associated with toxin-producing organism at a mucosal site, may involved disease at a deeper site. Associated with tampon use, wound infection or burns. 5-15% case fatality rate. Rx: Nafcillin AND clindamycin as initial therapy. Can also use Cefazolin or [[vancomycin]] in place of Nafcillin if MRSA suspected. IVIG 1 g/kg may bind toxins, but should be reserved for life-threatening infections.  
'''[[Staphylococcal]]: '''Most often associated with toxin-producing organism at a mucosal site, may involved disease at a deeper site. Associated with tampon use, wound infection or burns. 5-15% case fatality rate. Rx: [[Nafcillin]] AND [[clindamycin]] initially. Substitute [[cefazolin]] or [[vancomycin]] for nafcillin if MRSA suspected. [[IVIG]] 1 g/kg may bind toxins, but should be reserved for life-threatening infections.  


'''Streptococcal: '''Invasive disease at a deep site is the rule; deep site infection should be sought aggressively and treated. Defined as isolation of ''GAS'', hypotension, renal impairment, coagulopathy, ARDS and soft tissue necrosis. Associated with erisypelas, [[Necrotizing Fascitis]], secondary infection of varicella. Rx: Once streptococcus is identified, change therapy to Pencillin or other [[ß-lactam]] antibiotic PLUS Clindamycin.  
'''[[Streptococcal]]: '''Invasive disease at a deep site is the rule; deep site infection should be sought aggressively and treated. Defined as isolation of ''GAS'', hypotension, renal impairment, coagulopathy, ARDS and soft tissue necrosis. Associated with erysipelas, [[Necrotizing Fascitis]], secondary infection of varicella. Rx: Once streptococcus is identified, change therapy to [[penicillin]] or other [[ß-lactam]] antibiotic PLUS Clindamycin.  


|-
|-
| rowspan="2" | Central line infection  
| rowspan="2" | [[Central line]] infection  
| ''Coagulase-negative Staph (CONS), S. aureus, GN-bacilli, Candida spp.''  
| ''Coagulase-negative Staph (CONS), [[S. aureus]], GN-bacilli, [[Candida]] spp.''  
| rowspan="1" |  
| rowspan="1" |  
''Coagular-negative Staph (CONS)'': can try to salvage catheter with 10-14 days of therapy ([[vancomycin]]), 80% cure rate for exit site infections, 25% if deeper.  
''Coagulase-negative Staph (CONS)'': can try to salvage catheter with 10-14 days of therapy ([[vancomycin]]), 80% cure rate for exit site infections, 25% if deeper.  


If ''S. aureus'', ''[[Gram-Negative]] bacilli'' or ''Candida'': always remove the catheter if possible. ''S. aureus ''has a 10% exit site cure rate and 0% deeper infection cure rate if catheter left in.  
If ''[[S. aureus]]'', ''[[Gram-Negative]] bacilli'' or ''[[Candida]]'': always remove the catheter if possible. ''S. aureus ''has a 10% exit site cure rate and 0% deeper infection cure rate if catheter left in.  


If septic thrombophlebitis, [[endocarditis]], [[osteomyelitis]] or repeated positive cultures, ALWAYS remove catheter.  
If septic thrombophlebitis, [[endocarditis]], [[osteomyelitis]] or repeated positive cultures, ALWAYS remove catheter.  
Line 63: Line 63:
|-
|-
| TPN/Intralipids: as above and ''Malassezia furfur''  
| TPN/Intralipids: as above and ''Malassezia furfur''  
| rowspan="1" | Remove catheter and discontinue antimicrobials if possible. If ''Candida albicans'', treat with Fluconazole 6-12mg/kg/day IV Q24 (if &gt;14 days old) x 28 days OR conventional [[Amphotericin B]] 1mg/kg/day IV div Q24. If ''Staph epi'', treat with [[vancomycin]] and discontinue intralipids. If ''M. furfur'', treat with conventional [[Amphotericin B]].
| rowspan="1" | Remove catheter and discontinue antimicrobials if possible. If ''[[Candida albicans]]'', treat with [[Fluconazole]] 6-12mg/kg/day IV Q24 (if >14 days old) x 28 days OR conventional [[Amphotericin B]] 1mg/kg/day IV div Q24. If ''[[Staph epidermidis]]'', treat with [[vancomycin]] and discontinue intralipids. If ''M. furfur'', treat with conventional [[Amphotericin B]].
|-
|-
| [[Fever and Neutropenia]]
| [[Fever and Neutropenia]]
| ''Aerobic GNR, Strep. viridans, MRSA''
| ''Aerobic GNR, [[Strep viridans]], MRSA''
|  
|  
Piperacillin-Tazobactam 400mg/kg/day IV div Q6 OR Ceftzidime 150mg/kg/day IV div Q8 OR Meropenem 60mg/kg/day IV div Q8. Consider adding Gentamicin if persistently ill-appearing. Consider adding [[vancomycin]] if MRSA or coagulase-negative Staph suspected.  
[[Piperacillin-tazobactam]] 400mg/kg/day IV div Q6 OR [[Ceftzidime]] 150mg/kg/day IV div Q8 OR [[Meropenem]] 60mg/kg/day IV div Q8. Consider adding [[gentamicin]] if persistently ill-appearing. Consider adding [[vancomycin]] if MRSA or coagulase-negative Staph suspected.  


Consider adding Amphotericin B 1mg/kg/day IV Q24 if persistently febrile &gt;5 days on antibiotics. Consider Meropenem alone or addition of Metronidazole if typhilitis suspected.  
Consider adding [[amphotericin B]] 1mg/kg/day IV Q24 if persistently febrile >5 days on antibiotics. Consider [[meropenem]] alone or addition of [[metronidazole]] if [[typhlitis]] suspected.  


|-
|-
Line 76: Line 76:
| ''[[Borrelia burgdorferi]]''  
| ''[[Borrelia burgdorferi]]''  
|  
|  
Early rash (erythema migrans), carditic, facial nerve palsy, [[meningitis]]/[[encephalitis]], arthritis.  
Early rash (erythema migrans), carditic, facial nerve palsy, [[meningitis]]/[[encephalitis]], [[arthritis]].  


*Early localized/disseminated disease: Doxycycline 4mg/kg/day PO div BID (if &gt;7 yo) OR Amoxicillin 50mg/kg/day PO (max 1.5 g/day) div TID x14-21 days. Alternative Erythromycin 30mg/kg/day IV div Q8.  
*Early localized/disseminated disease: [[doxycycline]] 4mg/kg/day PO div BID (if >7 yo) OR [[amoxicillin]] 50mg/kg/day PO (max 1.5 g/day) div TID x14-21 days. Alternative [[erythromycin]] 30mg/kg/day IV div Q8.  
*Arthritis (no CNS disease): As above x28 days.<br>  
*Arthritis (no CNS disease): As above x28 days.<br>  
*[[Bell's Palsy]]: As above x21-28 days.<br>  
*[[Bell's Palsy]]: As above x21-28 days.<br>  
*Neuroborreliosis (CNS): [[ceftriaxone]] 75-100mg/kg/day IV Q24 OR Pencillin G 300,000 U/kg/day IV div Q4 x14-21 days.<br>
*Neuroborreliosis (CNS): [[ceftriaxone]] 75-100mg/kg/day IV Q24 OR [[penicillin G]] 300,000 U/kg/day IV div Q4 x14-21 days.<br>


|-
|-
Line 89: Line 89:
Suspect if fever, rash (95%), petechiae spreading from distal to central. Confirm with antibody titers. Ticks most often in Mid-Atlantic states. Treat empirically and aggressively, can be fatal.  
Suspect if fever, rash (95%), petechiae spreading from distal to central. Confirm with antibody titers. Ticks most often in Mid-Atlantic states. Treat empirically and aggressively, can be fatal.  


#Doxycycline 4mg/kg/day PO div BID x7-10 days (recommend for all age groups).<br>
#[[Doxycycline]] 4mg/kg/day PO div BID x7-10 days (recommend for all age groups).<br>


|-
|-
Line 97: Line 97:
Suspect if febrile, flu-like illness with rash in April-Sept. Leukopenia and thrombocytopenia common. 80% have positive blood smear (HGE only). Dx HME with PCR. Confirm with DFA. Commonly co-infected with ''B. burgdorferi<u></u>''.  
Suspect if febrile, flu-like illness with rash in April-Sept. Leukopenia and thrombocytopenia common. 80% have positive blood smear (HGE only). Dx HME with PCR. Confirm with DFA. Commonly co-infected with ''B. burgdorferi<u></u>''.  


#Doxycyline 4mg/kg/day PO div BID x7 days.<br>
#[[Doxycycline]] 4mg/kg/day PO div BID x7 days.<br>


|}
|}
Line 118: Line 118:
==[[Mastoiditis]], acute==
==[[Mastoiditis]], acute==
''S. pneumo ''(22%), ''S. pyogenes ''(16%), ''S. aureus ''(7%), ''H. flu, P. aeruginosa''  
''S. pneumo ''(22%), ''S. pyogenes ''(16%), ''S. aureus ''(7%), ''H. flu, P. aeruginosa''  
R/O [[meningitis]]. Surgical debridement as indicated. Transition to PO once clinically improved. Ampicillin-Sulbactam (Unasyn) 300mg/kg/dau IV div Q6 OR Cefotaxime 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24 +/- Nafcillin 200mg/kg/day IV div Q6 OR Clindamycin 40mg/kg/day IV div Q6 or [[vancomycin]] x21 days.
R/O [[meningitis]]. Surgical debridement as indicated. Transition to PO once clinically improved. [[Ampicillin-sulbactam]] 300mg/kg/dau IV div Q6 OR [[cefotaxime]] 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24 +/- [[nafcillin]] 200mg/kg/day IV div Q6 OR [[clindamycin]] 40mg/kg/day IV div Q6 or [[vancomycin]] x21 days.


==[[Sinusitis]], acute==
==[[Sinusitis]], acute==
#Amoxicillin 90mg/kg/day x14-21 days.<br>  
#[[Amoxicillin]] 90mg/kg/day x14-21 days.<br>  
#Augmentin, Cefuroxime or Cefdinir if recent antibiotics or chronic sinusitis.
#[[Augmentin]], [[cefuroxime]] or [[cefdinir]] if recent antibiotics or chronic sinusitis.


==[[Conjunctivitis]]==
==[[Conjunctivitis]]==
*Adenovirus (types 3, 7)  
*[[Adenovirus]] (types 3, 7)  
**AKA pink eye. No treatment needed. Highly contagious. Cold artificial tears may help. NEVER treat with steroids except by an ophthalmologist!
**AKA pink eye. No treatment needed. Highly contagious. Cold artificial tears may help. NEVER treat with steroids except by an ophthalmologist!
*[[HSV]] types 1-2  
*[[HSV]] types 1-2  
Line 132: Line 132:
**Vidarbine ophthalmic ointment Q3 until 1 weeks after healthing.
**Vidarbine ophthalmic ointment Q3 until 1 weeks after healthing.
*''S. pneumo, H. flu''  
*''S. pneumo, H. flu''  
**Polymixin/trimethoprim ophthalmic solution 1 drop Q3 OR polymixin.bacitracin/Neosporin ophthalmic solution 1 drop Q3 x7-10 days.
**Polymyxin/trimethoprim ophthalmic solution 1 drop Q3 OR polymixin.bacitracin/Neosporin ophthalmic solution 1 drop Q3 x7-10 days.


==[[Dacryocystitis ]]==
==[[Dacryocystitis ]]==
Warm compresses and tear duct massage. No antimicrobial therapy usually needed. Oral antimicrobial therapy for more symptomatic infections.
*Warm compresses and tear duct massage. No antimicrobial therapy usually needed. Oral antimicrobial therapy for more symptomatic infections


==[[Orbital Cellulitis]]==
==[[Orbital Cellulitis]]==
Ampicillin-Sulbactam (Unasyn) 300mg/kg/day IV div Q6 OR Cefotaxime 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24 AND Nafcillin 200mg/kg/day IV div Q6. If any MRSA isolated locally, add Clindamycin 40mg/kg/day IV div Q6 OR [[vancomycin]] x10-14 days.  
*[[Ampicillin-sulbactam]] 300mg/kg/day IV div Q6 OR [[cefotaxime]] 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24 AND [[nafcillin]] 200mg/kg/day IV div Q6. If any MRSA isolated locally, add [[clindamycin]] 40mg/kg/day IV div Q6 OR [[vancomycin]] x10-14 days.


==[[Periorbital Cellulitis|Periorbital (preseptal) Cellulitis]]==
==[[Periorbital Cellulitis|Periorbital (preseptal) Cellulitis]]==
#If known entry site: Nafcillin 200mg/kg/day IV div Q6 OR Cefazolin 100mg/kg/day IV Q8 x7-10 days. If MRSA suspected, Vancomycin OR Clindamycin 40mg/kg/day IV div Q6. Oral antistaphylococcal antibiotics for less severe infections.  
#If known entry site: [[nafcillin]] 200mg/kg/day IV div Q6 OR [[cefazolin]] 100mg/kg/day IV Q8 x7-10 days. If MRSA suspected, [[Vancomycin]] OR [[clindamycin]] 40mg/kg/day IV div Q6. Oral antistaphylococcal antibiotics for less severe infections.  
#Periorbital swelling without cellulitis (often associated with sinusitis): [[Ceftriaxone]] 50mg/kg/day IV Q24 OR Cefotaxime 150mg/kg/day IV div Q8. ADD Clindamycin 40mg/kg/day IV div Q6 for more severe infections of suspicion of MRSA. See 'Head: Sinusitis' for oral therapy options.
#Periorbital swelling without cellulitis (often associated with sinusitis): [[Ceftriaxone]] 50mg/kg/day IV Q24 OR [[cefotaxime]] 150mg/kg/day IV div Q8. ADD [[clindamycin]] 40mg/kg/day IV div Q6 for more severe infections of suspicion of MRSA. See 'Head: Sinusitis' for oral therapy options.


==[[Otitis Externa]]==
==[[Otitis Externa]]==
*Clean canal often.  
*Clean canal often.  
*Neomycin/Polymixin B +/- hydrocortisone otic drops. Alternate: Ofloxacin or Ciprofloxacin solution. For 'swimmers ear' use VoSol (2% acetic acid) to canal.  
*[[Hydrocortisone/neomycin/polymyxin|Neomycin/Polymixin B +/- hydrocortisone]] otic drops. Alternate: [[Ofloxacin]] or [[ciprofloxacin]] solution. For 'swimmers ear' use VoSol (2% acetic acid) to canal.  
*Candidal: Fluconazole 5-10mg/kg/day PO Q24 x5-7 days.  
*Candidal: [[Fluconazole]] 5-10mg/kg/day PO Q24 x5-7 days.  


==[[Otitis Media]]==
==[[Otitis Media]]==
'''Note: '''If >2 years, afebrile, no otalgia, borderline exam → consider symtomatic treatment or safety net antibiotic prescription (SNAP).  
'''Note: '''If >2 years, afebrile, no otalgia, borderline exam → consider symptomatic treatment or safety net antibiotic prescription (SNAP).  


#Amoxicillin 80-90mg/kg/day div BID or TID x10 days (&lt;2 years) or x5 days (&gt;2 years).  
#[[Amoxicillin]] 80-90mg/kg/day div BID or TID x10 days (<2 years) or x5 days (>2 years).  
#Augmentin 90mg/kg/day amoxcillin component div BID.  
#[[Augmentin]] 90mg/kg/day amoxicillin component div BID.  
#Cefdinir (Omnicef), Cefpodoxime, Cefprozil, Cefuroxime. Zithromax (up to 40% resistance in PRSP).
#[[Cefdinir]], [[cefpodoxime]], [[cefprozil]], [[cefuroxime]]. [[Azithromycin]] (up to 40% resistance in PRSP).


==[[Ludwig's Angina]]==
==[[Ludwig's Angina]]==
High risk of respiratory tract obstruction due to inflammatory edema.  
High risk of respiratory tract obstruction due to inflammatory edema.  


#Penicillin G 200,000 U/kg/day div Q6 AND Clindamycin 40mg/kg/day IV vid Q6.  
#[[Penicillin G]] 200,000 U/kg/day div Q6 AND [[clindamycin]] 40mg/kg/day IV vid Q6.  
#Consider Meropenem, Piperacillin-Tazobactam (Zosyn) OR [[ceftriaxone]] if [[GNR]] suspected.
#Consider  
[[meropenem]], [[piperacillin-tazobactam]] OR [[ceftriaxone]] if [[GNR]] suspected.


==[[Dental abscess]]==
==[[Dental abscess]]==
#Clindamycin 40mg/kg/day PO/IV/IM div Q6 or Pencillin G 100,000-200,000 U/kg/day IV div Q6.
#[[Clindamycin]] 40mg/kg/day PO/IV/IM div Q6 or [[Penicillin G]] 100,000-200,000 U/kg/day IV div Q6.


==[[Gingivostomatitis]]==
==[[Gingivostomatitis]]==
Acyclovir PO 80mg/kg/day div Q6 x7 days. For severe disease can use Acyclovir 30mg/kg/day IV div Q8.
*[[Acyclovir]] PO 80mg/kg/day div Q6 x7 days. For severe disease can use Acyclovir 30mg/kg/day IV div Q8.


==[[Bacterial tracheitis]]==
==[[Bacterial tracheitis]]==
#([[Vancomycin OR Clindamycin 40mg/kg/day div Q6) AND (Cefotaxime 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24). Tailor to cultures.  
#([[Vancomycin]] OR [[clindamycin]] 40mg/kg/day div Q6) AND ([[Cefotaxime]] 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24). Tailor to cultures.  
#Cefuroxime 100-150mg/kg/day div Q8.
#[[Cefuroxime]] 100-150mg/kg/day div Q8.


==[[Epiglottitis]]==
==[[Epiglottitis]]==
Cefotaxime 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24. ADD Clindamycin 40mg/kg/day IV div Q6 OR [[vancomycin]] if Staph suspected.  
*[[Cefotaxime]] 150mg/kg/day div Q8 OR [[ceftriaxone]] 50mg/kg/day Q24. ADD Clindamycin 40mg/kg/day IV div Q6 OR [[vancomycin]] if Staph suspected.


==[[Pharyngitis]]==
==[[Pharyngitis]]==
Throat: Culture before treating. ''GAS'' uncommon in children &lt;3 years. Treatment decrease rheumatic fever 2.8 to 0.2%. Rx as below also for scarlet fever.  
*Throat: Culture before treating. ''GAS'' uncommon in children <3 years. Treatment decrease rheumatic fever 2.8 to 0.2%. Rx as below also for scarlet fever.  


#Penicillin V 25-50mg/kg/day PO div TID-QID OR Amoxicillin 50-75mg/kg/day div BID-TID x10 days.  
#[[Penicillin]] V 25-50mg/kg/day PO div TID-QID OR [[amoxicillin]] 50-75mg/kg/day div BID-TID x10 days.  
#Pencillin G Benzathine 600,000 U IM (&lt;27 kg), 1.2 million U (&gt;27 kg) x1.  
#[[Penicillin G]] Benzathine 600,000 U IM (<27 kg), 1.2 million U (>27 kg) x1.  
#Erythromycin or Clindamycin for PCN-allergic patients.
#[[Erythromycin]] or [[clindamycin]] for PCN-allergic patients.


= Respiratory Tract Infections  =
= Respiratory Tract Infections  =
Line 187: Line 188:


==[[Whooping cough]]==
==[[Whooping cough]]==
#Erythromycin ethyl succinate 40mg/kg/day PO div QID x14 days (max 2000mg/day). Note: Do not use erythromycin base, which causes excessive GI symptoms.  
#[[Erythromycin]] ethyl succinate 40mg/kg/day PO div QID x14 days (max 2000mg/day). Note: Do not use erythromycin base, which causes excessive GI symptoms.  
#Azithromycin (&lt;6 months): 10mg/kg once daily x5 days (max 500mg). Note: Preferred agent for patients &lt;1 month.
#[[Azithromycin]] (<6 months): 10mg/kg once daily x5 days (max 500mg). Note: Preferred agent for patients <1 month.  
#Azithromycin (&lt;6 months): 10mg/kg x1 dose (max 500mg), then 5mg/kg once daily x4 days (max 250mg).


==Cardiovascular Infections ==
==Cardiovascular Infections==
===[[Endocarditis]]===
===[[Endocarditis]]===
'''Prophylaxis indications'''  
'''Prophylaxis indications'''  
Line 198: Line 198:
Previous infectious endocarditis.  
Previous infectious endocarditis.  


Congenital heart disease (CHD) - except for the conditions listed below, antibiotic prophylaxis is no longer recommended for any other form of CHD.  
[[Congenital heart disease]] (CHD) - except for the conditions listed below, antibiotic prophylaxis is no longer recommended for any other form of CHD.  


*Unrepaired cyanotic CHD, including palliative shunts and conduits.  
*Unrepaired cyanotic CHD, including palliative shunts and conduits.  
*Completely repaired CHD with prosthetic material or device, whether placed by surgery or by catheter intervenion, during the first 6 months after the procedure.  
*Completely repaired CHD with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure.  
*Repaired CHD with residual defects at the site or adjacent to the site or a prosthetic patch or prosthetic device (which inhibit endotheliazation).
*Repaired CHD with residual defects at the site or adjacent to the site or a prosthetic patch or prosthetic device (which inhibit endothelialization).


Cardiac transplantation recipients who develop cardiac valvulopathy.  
Cardiac transplantation recipients who develop cardiac valvulopathy.  


'''Prophylaxis for oral, dental, respiratory tract or high risk patients with chronic GI/GU infections '''
'''Prophylaxis for oral, dental, respiratory tract or high risk patients with chronic GI/GU infections '''
#Amoxicillin 50mg/kg PO x1 OR Ampicillin 50mg/kg IV x1, 30-60 minutes prior to the procedure.  
#[[Amoxicillin]] 50mg/kg PO x1 OR Ampicillin 50mg/kg IV x1, 30-60 minutes prior to the procedure.  
#Allergic patients: Clindamycin 20mg/kg PO/IV x1 OR [[cephalexin]] 50mg/kg PO x1 OR Azithromycin 15mg/kg PO x1.
#Allergic patients: [[Clindamycin]] 20mg/kg PO/IV x1 OR [[cephalexin]] 50mg/kg PO x1 OR [[azithromycin]] 15mg/kg PO x1.


'''Empiric therapy, native valves: S. viridnas, Enterococci, Staphylococci'''
'''Empiric therapy, native valves: S. viridans, Enterococci, Staphylococci'''


By definition includes multiple positive [[blood cultures]], new murmur of valvular insufficiency, emboli and echo evidence of vegetations. Send cultures and target therapy based on results. [[Vancomycin]] and Gentamicin pending culture results.
By definition includes multiple positive [[blood cultures]], new murmur of valvular insufficiency, emboli and echo evidence of vegetations. Send cultures and target therapy based on results. [[Vancomycin]] and Gentamicin pending culture results.


==Gastroenterologic Infections ==
==Gastroenterologic Infections==


{| cellspacing="0" cellpadding="2" border="1" align="left"
{| cellspacing="0" cellpadding="2" border="1" align="left"
Line 220: Line 220:
| rowspan="7" | [[Diarrhea]]
| rowspan="7" | [[Diarrhea]]
| colspan="2" |  
| colspan="2" |  
'''Initial Workup:''' If blood diarrhea or &gt;6 stools/day and febrile then consider stool cultures, fecal leukocytes, electrolytes.  
'''Initial Workup:''' If blood diarrhea or >6 stools/day and febrile then consider stool cultures, fecal leukocytes, electrolytes.  


'''Isolation:''' Contact precautions for diapered or incontinent children.  
'''Isolation:''' Contact precautions for diapered or incontinent children.  
Line 229: Line 229:
Suspect if blood diarrhea, cramping develop with recent antibiotic exposure.  
Suspect if blood diarrhea, cramping develop with recent antibiotic exposure.  


#Metronidazole 30mg/kg/day PO/IV div QID x10 days.  
#[[Metronidazole]] 30mg/kg/day PO/IV div QID x10 days.  
#[[Vancomycin]] 40mg/kg/day PO&nbsp;div QID x10 days ONLY for Metronidazole failures.
#[[Vancomycin]] 40mg/kg/day PO;div QID x10 days ONLY for Metronidazole failures.


|-
|-
Line 237: Line 237:
Suspect if prominent abdominal pain. Young infants may only have bloody diarrhea. Can have immunoreactive complications such as AIDP, reactive arthritis, Reiter syndrome or erythema nodosum.  
Suspect if prominent abdominal pain. Young infants may only have bloody diarrhea. Can have immunoreactive complications such as AIDP, reactive arthritis, Reiter syndrome or erythema nodosum.  


#Erythromycin 40mg/kg/day PO div QID x5 days. Shortens duration of illness and prevents relapse if given early.
#[[Erythromycin]] 40mg/kg/day PO div QID x5 days. Shortens duration of illness and prevents relapse if given early.  
#Ciprofloxacin if &gt;18 yo.


|-
|-
|  
|  
''E. coli O157:H7''  
''[[E. coli]] O157:H7''  


''(Enterotoxin producing, ETEC)''  
''(Enterotoxin producing, ETEC)''  


| Suspect if bloody diarrhea, &gt;6 unformed stools/day and afebrile. Causes 36% of bloody diarrhea. Consider CBC and blood smear. If no hemolysis, azotemia or thrombocytopenia after 3 days of illness, risk of developing HUS is low. Antimicrobial therapy may precipitate an adverse reaction.<br>
| Suspect if bloody diarrhea, >6 unformed stools/day and afebrile. Causes 36% of bloody diarrhea. Consider CBC and blood smear. If no hemolysis, azotemia or thrombocytopenia after 3 days of illness, risk of developing HUS is low. Antimicrobial therapy may precipitate an adverse reaction.<br>
|-
|-
| ''Salmonella''<br>  
| ''[[Salmonella]]''<br>  
|  
|  
May cause asymptomatic disease, gastroenteritis, bacteremia, osteomyelitis or meningitis. Exposures to lizards and other reptiles may result in unusual species of ''Salmonella''.  
May cause asymptomatic disease, gastroenteritis, bacteremia, osteomyelitis or meningitis. Exposures to lizards and other reptiles may result in unusual species of ''Salmonella''.  


#Antimicrobial therapy increases duration of illness in most carriers.<br>  
#Antimicrobial therapy increases duration of illness in most carriers.<br>  
#Therapy recommended if invasive or focal disease, if &lt;3 months old, chronic GI disease, oncology patients, hemoglobinopathies, or HIV+. May treat with Amoxicillin or TMP-SMX; Ceftriaxone for neonates (not receiving calcium containing fluids) or septic clinical state.<br>
#Therapy recommended if invasive or focal disease, if <3 months old, chronic GI disease, oncology patients, hemoglobinopathies, or HIV+. May treat with [[amoxicillin]] or [[TMP-SMX]]; [[Ceftriaxone]] for neonates (not receiving calcium containing fluids) or septic clinical state.<br>


|-
|-
| ''Shigella''<br>  
| ''[[Shigella]]''<br>  
|  
|  
Suspect if fever, cramps, tenesmus, abdominal pain. Complications include seizures, bacteremia, Reiter Syndrome, HUS (''S. dystenteriae&nbsp;''type 1), toxic megacolon and toxic encephalopathy (ekiri syndrome).  
Suspect if fever, cramps, tenesmus, abdominal pain. Complications include seizures, bacteremia, Reiter Syndrome, HUS (''S. dystenteriae;''type 1), toxic megacolon and toxic encephalopathy (ekiri syndrome).  


#Cefixime 8mg/kg/day PO div BID or [[TMP-SMX]] (Bactrim) 8mg/kg/day TMP PO div TID x5-7 days. Illness usually self-limited (48-72 hours), but treatment is always indicated to decrease duration of shedding, which is important for public health measures.<br>
#[[Cefixime]] 8mg/kg/day PO div BID or [[TMP-SMX]] 8mg/kg/day TMP PO div TID x5-7 days. Illness usually self-limited (48-72 hours), but treatment is always indicated to decrease duration of shedding, which is important for public health measures.<br>


|-
|-
| ''Yersinia enterocolitica''<br>  
| ''[[Yersinia enterocolitica]]''<br>  
| Causes mesenteric adenitis, mimics appendicitis. Predisposed by iron overload states (chronic transfusions). Antimicrobial therapies not indicated in normal hosts.<br>
| Causes mesenteric adenitis, mimics appendicitis. Predisposed by iron overload states (chronic transfusions). Antimicrobial therapies not indicated in normal hosts.<br>
|-
|-
Line 271: Line 270:
Bacteremia in 30-50% of cases. Definitive antimicrobial therapy based on culture results. ''B. fragilis ''invades gut after several days of age.  
Bacteremia in 30-50% of cases. Definitive antimicrobial therapy based on culture results. ''B. fragilis ''invades gut after several days of age.  


#Ampicillin AND Gentamicin x10 or more days<br>
#[[Ampicillin]] AND [[gentamicin]] x10 or more days<br>


Consider adding Cefotaxime if CNS involvement cannot be exclused. Consider replacing Ampicillin with [[vancomycin]] if MRSA/CONS. Consider adding Clindamycin if perforation cannot be excluded.<br>  
Consider adding [[cefotaxime]] if CNS involvement cannot be excluded. Consider replacing [[ampicillin]] with [[vancomycin]] if MRSA/CONS. Consider adding [[clindamycin]] if perforation cannot be excluded.<br>  


|-
|-
Line 279: Line 278:
| ''Enteric GNR, Bacteroides sp., Enterococcus sp.''<br>  
| ''Enteric GNR, Bacteroides sp., Enterococcus sp.''<br>  
|  
|  
#Meropenem 60mg/kg/day IV div Q8 OR Piperacillin-Tazobactam 400mg/kg/day IV div Q6 x7-10 days.<br>  
#[[Meropenem]] 60mg/kg/day IV div Q8 OR [[piperacillin-tazobactam]] 400mg/kg/day IV div Q6 x7-10 days.<br>  
#Ampicillin 150mg/kg/day IV div Q8 AND Gentamicin (dose per age) IV div Q8 AND [Clindamycin 40mg/kg/day IV Q6 OR Metronidazole 30mg/kg/day IV div Q6] x7-10 days.<br>
#[[Ampicillin]] 150mg/kg/day IV div Q8 AND [[gentamicin]] (dose per age) IV div Q8 AND [[clindamycin]] 40mg/kg/day IV Q6 OR [[metronidazole]] 30mg/kg/day IV div Q6] x7-10 days.<br>


|-
|-
| Peritonitis (peritoneal dialysis)<br>  
| Peritonitis (peritoneal dialysis)<br>  
| ''Staphylococci, GNs, ''yeast<br>  
| ''Staphylococci, GNs, ''yeast<br>  
| Antibiotic added to dialysate in concentrations approximating those attained in serum for systemic disease (Gentamicin 8mg/L, Vancomycin 50mg/L).<br>
| Antibiotic added to dialysate in concentrations approximating those attained in serum for systemic disease [[gentamicin]] 8mg/L, [[Vancomycin]] 50mg/L).<br>
|}
|}
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>


==Genitourinary Infections==
==Genitourinary Infections==
===[[Pyelonephritis]]===
===[[Pyelonephritis]]===
Inpatient: Ceftriaxone 50mg/kg/day IV/IM Q24 OR Genamicin (age based dosing) OR TMP/SMX (Bactrim) 8mg/kg/day IV div BID x14 days. Treat IV until defervesces and clinically improved, then transition to PO.
Inpatient: [[Ceftriaxone]] 50mg/kg/day IV/IM Q24 OR [[gentamicin]] (age based dosing) OR [[TMP/SMX] 8mg/kg/day IV div BID x14 days. Treat IV until defervesces and clinically improved, then transition to PO.


Outpatient: TMP-SMX (Bactrim) OR Cefixime OR Ciprofloxacin (in adolescents); see doses under UTI
Outpatient: [[TMP-SMX]] OR [[cefixime]] OR [[ciprofloxacin]] (in adolescents); see doses under UTI


===[[UTI]]===
===[[UTI]]===
'''Inpatient: '''>2 months: Cefotaxime or Ceftriaxone until taking PO, well appearing → transition to outpatient therapy.  
'''Inpatient: '''>2 months: [[cefotaxime]] or [[ceftriaxone]] until taking PO, well appearing → transition to outpatient therapy.  


'''Outpatient: '''(Infants and Children): TMP-SMX (Bactrim) 6-10mg/kg/day TMP component div BID OR Cefixime 16mg/kg/day x1 day, then 8mg/kg/day Q24 (max 400mg/dose) OR [[Cephalexin]] 25mg/kg/dose QID (max 1000mg/dose) x7-14 days. Alternatives: Nitrofurantoin, Ciprofloxacin, Ceftriaxone. (Adults): Bactrim DS BID x3 days or Ciprofloxacin 250mg BID x3 days.<br>
'''Outpatient: '''(Infants and Children): [[TMP-SMX]] 6-10mg/kg/day TMP component div BID OR [[cefixime]] 16mg/kg/day x1 day, then 8mg/kg/day Q24 (max 400mg/dose) OR [[cephalexin]] 25mg/kg/dose QID (max 1000mg/dose) x7-14 days. Alternatives: [[nitrofurantoin]], [[ciprofloxacin]], [[ceftriaxone]]. <br>


==Skin &amp; Soft Tissue Infections<br> ==
==Skin &amp; Soft Tissue Infections<br>==
===[[Skin abscess]]===
===Skin [[abscess]]===
*OSSA/MSSA - [[Cephalexin]] 50-75mg/kg/day PO div TID OR Augmentin 80-90mg/kg/day PO div BID x5-7 days. '''I&amp;D when indicated.'''<br>  
*OSSA/MSSA - [[Cephalexin]] 50-75mg/kg/day PO div TID OR [[Augmentin]] 80-90mg/kg/day PO div BID x5-7 days. '''I&amp;D when indicated.'''<br>  
*If MRSA prevalent or if recurrent abscess, send specimen for culture and sensitivity. Treat with Clindamycin 40mg/kg/day IV div Q6 or [[TMP-SMX]] (Bactrim) 5mg/kg/dose TMP Q6-8. If toxic-appearing, use [[vancomycin]].
*If MRSA prevalent or if recurrent abscess, send specimen for culture and sensitivity. Treat with [[clindamycin]] 40mg/kg/day IV div Q6 or [[TMP-SMX]] 5mg/kg/dose TMP Q6-8. If toxic-appearing, use [[vancomycin]].


===[[Cellulitis]]===
===[[Cellulitis]]===
Start IV: Clindamycin 40mg/kg/day IV div Q6 if high community incidence of MRSA. May use Nafcillin 200mg/kg/day IV div Q6 OR Cefazolin 100mg/kg/day IV div Q8 if low incidence of MRSA. Transition to PO when stable. If no improvement, change to Vancomycin (dose by age).  
*Start IV: [[Clindamycin]] 40mg/kg/day IV div Q6 if high community incidence of MRSA. May use [[nafcillin]] 200mg/kg/day IV div Q6 OR [[cefazolin]] 100mg/kg/day IV div Q8 if low incidence of MRSA. Transition to PO when stable. If no improvement, change to [[vancomycin]] (dose by age).  


PO: [[Cephalexin]] 50-75mg/kg/day divided TID OR Dicloxacillin 50mg/kg/day PO div Q6. Total duration of treatment 7-10 days.  
*PO: [[Cephalexin]] 50-75mg/kg/day divided TID OR [[dicloxacillin]] 50mg/kg/day PO div Q6. Total duration of treatment 7-10 days.


===[[Erysipelas]]===
===[[Erysipelas]]===
Penicillin G IV, then transition to Pencicillin V or Amoxicillin PO&nbsp;x10 days.<br>
*[[Penicillin G]] IV, then transition to [[penicillin]] V or [[amoxicillin]] PO;x10 days.<br>


===[[Impetigo]]===
===[[Impetigo]]===
*Mupirocin topical to lesions TID, cleanse with soap and water. Bathe daily. If extensive, treat with [[Cephalexin]] PO or Amoxicillin-Clavunate x5-7 days.
*[[Mupirocin]] topical to lesions TID, cleanse with soap and water. Bathe daily. If extensive, treat with [[cephalexin]] PO or [[amoxicillin-clavulanate]] x5-7 days.


===Omphalitis/Funisitis===
===Omphalitis/Funisitis===
Empiric: Cefotaxime AND Clindamycin x10 or more days. If MRSA prevalent, Amoxicillin, [[Cephalexin]].  
*Empiric: [[Cefotaxime]] AND [[clindamycin]] x10 or more days.  


Funisitis (local infection of cord): cord care, topical antimicrobials.  
*Funisitis (local infection of cord): cord care, topical antimicrobials.


===[[Paronychia]]===
===[[Paronychia]]===
*Local wound care and I&D unless signs of spreading infection, then consider Augmentin or Clindamycin.
*Local wound care and I&D unless signs of spreading infection, then consider [[Augmentin]] or [[clindamycin]].


===[[Scabies]]===
===[[Scabies]]===
#Topical 5% Permethrin cream, apply to neck down, wash off in 8-14 hours.<br>  
#Topical 5% [[permethrin]] cream, apply to neck down, wash off in 8-14 hours.<br>  
#Topical Lindane 1%, 1 oz lotion/30 g cream, apply to neck down, wash off in 8 hours.
#Topical Lindane 1%- ''Avoid unless treatment failure to permethrin due to risk of neurotoxicity. Many contraindications/precautions!''
 
===[[Staph scaled skin syndrome]]===
#Nafcillin 200mg/kg/day IV div Q6 OR Cefazolin IV x5-7 days. Consider [[vancomycin]].


===[[Staphylococcal scalded skin syndrome]]===
#[[Nafcillin]] 200mg/kg/day IV div Q6 OR Cefazolin IV x5-7 days. Consider [[vancomycin]].
Avoid TMP-SMX.  
Avoid TMP-SMX.  


===[[Tinea corporis]]===
===[[Tinea corporis]]===
May use one of many topical antifungal agents: Terbinafine 1% cream or gel BID to affected areas; Clotrimazole 1% cream, lotion or solution; others include Econazole, Sulconazole, Oxiconazole, Naftifine, Cicloprox, Ketoconazole, Sertaconazle, Moconazole and Tolnaftate. Treat for 14 days. Keep affected areas dry.<br>
*May use one of many topical antifungal agents: [[Terbinafine]] 1% cream or gel BID to affected areas; [[clotrimazole]] 1% cream, lotion or solution; others include Econazole, Sulconazole, Oxiconazole, Naftifine, Cicloprox, Ketoconazole, Sertaconazle, Moconazole and Tolnaftate. Treat for 14 days. Keep affected areas dry.<br>


===[[Tinea capitis]]===
===[[Tinea capitis]]===
Griseofulvin Microsize 10-20mg/kg/day div Q12-24 (max 1000mg/day) OR Griseofulfin Ultramicrosize &gt;2 years 5-10mg/kg/day div Q12-24 x6 weeks] AND Selenium sulfide shampoo twice weekly x1 week as directed.
*[[Griseofulvin]] Microsize 10-20mg/kg/day div Q12-24 (max 1000mg/day) OR [[Griseofulvin]] Ultramicrosize >2 years 5-10mg/kg/day div Q12-24 x6 weeks] AND [[Selenium sulfide]] shampoo twice weekly x1 week as directed.


===[[Necrotizing Fasciitis]]===
===[[Necrotizing Fasciitis]]===
#Prompt surgical debridement and cultures. Send for cultures and sensitivites.<br>  
#Prompt surgical debridement and cultures. Send for cultures and sensitivities.<br>  
#Treat with Clindamycin AND [Zosyn OR Cefotaxime]. For proven streptococcal disease, Penicillin and Clindamycin suffice.
#Treat with [[clindamycin]] AND [[Zosyn]] OR [[cefotaxime]]. For proven streptococcal disease, [[penicillin]] and [[clindamycin]] suffice.




Line 424: Line 349:
Treat all bat and feral cat exposures with both HRIG and [[Rabies]] vaccine as below. Otherwise, treat with vaccine and contact public health officials or infection control for advice on whether to treat with HRIG. Monitor animal for 10 days.  
Treat all bat and feral cat exposures with both HRIG and [[Rabies]] vaccine as below. Otherwise, treat with vaccine and contact public health officials or infection control for advice on whether to treat with HRIG. Monitor animal for 10 days.  


#[[Rabies]] vaccine 1 mL&nbsp;IM into deltoid days 0, 3, 7, 14 and 28.  
#[[Rabies]] vaccine 1 mL;IM into deltoid days 0, 3, 7, 14 and 28.  
#HRIG 20 IU/kg around wound and begin vaccination series with HDCV or&nbsp;RVA vaccine days 0, 3, 7, 14 and 28.  
#HRIG 20 IU/kg around wound and begin vaccination series with HDCV or;RVA vaccine days 0, 3, 7, 14 and 28.  
#Consider treating with Augmentin as below.
#Consider treating with Augmentin as below.


Line 433: Line 358:
| Cat: ''Pasteurella multocida, S. aureus''<br>  
| Cat: ''Pasteurella multocida, S. aureus''<br>  
|  
|  
#Augmentin 45mg/kg/day div Q8-12 x5-7 days. For PCN allergic patients, ''Pasteurella ''is covered by Doxycycline or Ciprofloxacin. Add another drug for ''Strep&nbsp;''or ''Staph sp.''
#[[Augmentin]] 45mg/kg/day div Q8-12 x5-7 days. For penicillin allergic patients, ''Pasteurella ''is covered by [[doxycycline]] or [[ciprofloxacin]]. Add another drug for ''Strep;''or ''Staph sp.''
#Rabies: See above if feral cat. Check tetanus status.
#Rabies: See above if feral cat. Check tetanus status.


Line 439: Line 364:
| Dog: ''Pasteurella multocida, S. aureu''''s, Bacteroides, Fusobacterium, Capnophaga'''''<b><br></b>  
| Dog: ''Pasteurella multocida, S. aureu''''s, Bacteroides, Fusobacterium, Capnophaga'''''<b><br></b>  
|  
|  
#Augmentin 45mg/kg/day PO div Q8-12 x5-7 days<br>  
#[[Augmentin]] 45mg/kg/day PO div Q8-12 x5-7 days<br>  
#Rabies: see above. Check tetanus status.
#Rabies: see above. Check tetanus status.


|-
|-
| Human: ''Strep viridans&nbsp;''(100%), ''Staph epi ''(53%), ''Cornybacterium ''(41%), ''S. aureus ''(29%), ''Eikenella, Bacteroides, Peptostrep''<br>  
| Human: ''Strep viridans;''(100%), ''Staph epinephrine ''(53%), ''Cornybacterium ''(41%), ''S. aureus ''(29%), ''Eikenella, Bacteroides, Peptostrep''<br>  
|  
|  
High rates of infection. '''Do not close open wounds!'''  
High rates of infection. '''Do not close open wounds!'''  


#Early (no signs of infection): Augmentin 45mg/kg/day PO div Q8-12 x5-7 days.  
#Early (no signs of infection): [[Augmentin]] 45mg/kg/day PO div Q8-12 x5-7 days.  
#Late (signs of infection): Ampicillin-Sulbactam (Unasyn)&nbsp;IV. Can use Clindamycin AND Ampicillin.  
#Late (signs of infection): [[Ampicillin-sulbactam]] IV. Can use [[clindamycin]] AND [[ampicillin]].  
#Check tetanus status.
#Check tetanus status.


Line 454: Line 379:
| Rat or pig (polymicrobial, ''Sprillum minus'', ''Streptobacillus'')<br>  
| Rat or pig (polymicrobial, ''Sprillum minus'', ''Streptobacillus'')<br>  
|  
|  
#Augmentin 45mg/kg/day PO div Q8-12 x5-7 days<br>  
#[[Augmentin]] 45mg/kg/day PO div Q8-12 x5-7 days<br>  
#Rabies: see above. Check tetanus status.
#Rabies: see above. Check tetanus status.


|-
|-
| rowspan="2" | Lymphadenitis<br>  
| rowspan="2" | Lymphadenitis<br>  
| Localized infection: ''GAS, S. aureus (MRSA)...less likely anaerobes, M. Tb ''(scrofula), ''Toxoplasmosis, Tularemia, Sporotrichosis,&nbsp;''atypical mycobacterial (consider the latter if nonresponsive to antimicrobials)<br>  
| Localized infection: ''GAS, S. aureus (MRSA)...less likely anaerobes, M. Tb ''(scrofula), ''Toxoplasmosis, Tularemia, Sporotrichosis,;''atypical mycobacterial (consider the latter if nonresponsive to antimicrobials)<br>  
|  
|  
MSSA: Augmentin 90mg/kg/day PO div BID OR [[Cephalexin]] 100mg/kg/day PO div QID x10 days. If IV needed, Cefazolin 100mg/kg/day IV div Q8.  
MSSA: [[Augmentin]] 90mg/kg/day PO div BID OR [[Cephalexin]] 100mg/kg/day PO div QID x10 days. If IV needed, [[cefazolin]] 100mg/kg/day IV div Q8.  


MRSA: Clindamycin OR TMP-SMX OR Linezolid. If IV needed, Clindamycin 40mg/kg/day IV div Q6 OR [[vancomycin]] (age based dosing) x7-10 days total.  
MRSA: [[Clindamycin]] OR [[TMP-SMX]] OR [[linezolid]] OR [[vancomycin]] (age based dosing) x7-10 days total.  


|-
|-
| Cat-scratch disease: ''Bartonella henslae''<br>  
| Cat-scratch disease: ''Bartonella henslae''<br>  
|  
|  
Lymphadenitis common in axillary/epitrochlear nodes (46%), neck (26%), inguinal (17%). Treat for immunocomprimised host of signs of systemic illness&nbsp;(HSM).  
Lymphadenitis common in axillary/epitrochlear nodes (46%), neck (26%), inguinal (17%). Treat for immunocompromised host of signs of systemic illness;(HSM).  


#Azithromycin 10mg/kg/day PO Q24 x5 days.
#[[Azithromycin]] 10mg/kg/day PO Q24 x5 days.


May also use [[Bactrim]], Rifampin and Ciprofloxacin. Duration of therapy is uncertain.  
May also use [[Bactrim]], [[rifampin]] and [[ciprofloxacin]]. Duration of therapy is uncertain.  


|}
|}


==Orthopedic Infections ==
==Orthopedic Infections==
===[[Osteomyelitis]]===
===[[Osteomyelitis]]===
{{Osteomyelitis Antibiotics}}
{{Osteomyelitis Antibiotics}}


===[[Septic Arthritis]]===
===[[Septic Arthritis]]===
*If immunized against ''Hib'': Nafcillin 200mg/kg/day IV div Q6 OR Cefazolin 100mg/kg/day div Q8 x21 days.  
*If immunized against ''Hib'': [[Nafcillin]] 200mg/kg/day IV div Q6 OR [[cefazolin]] 100mg/kg/day div Q8 x21 days.  
*If unimmunized again ''Hib'': Cefuroxime OR [Cefotaxime AND [Nafcillin OR Cefazolin]] x21 days.  
*If unimmunized again ''Hib'': [[Cefuroxime]] OR [[cefotaxime]] AND [[nafcillin]] OR [[cefazolin]] x21 days.  
*If ''[[Gonococcus]]'' suspected or isolated, [[ceftriaxone]] 50mg/kg/day IV/IM daily OR Penicillin G IV (if susceptible) x7-10 days.
*If ''[[Gonococcus]]'' suspected or isolated, [[ceftriaxone]] 50mg/kg/day IV/IM daily OR [[penicillin G]] IV (if susceptible) x7-10 days.


==See Also==
==See Also==
*[[Antimicrobial Dosing (Peds)]]
{{Antibiotics by diagnosis navigation}}
{{Antibiotics by diagnosis navigation}}


=References=
==References==
<references/>
<references/>
[[Category:ID]] [[Category:Pharmacology]] [[Category:Pediatrics]]
[[Category:ID]] [[Category:Pharmacology]] [[Category:Pediatrics]]

Latest revision as of 23:07, 16 May 2020

Neonatal Infections

  • All doses are for patients >2 kg and at least 7 days of age
  • Always treat for meningitis until you are sure it is not

Pediatric fever of uncertain source

Neonatal (0-28 days)

^Acyclovir if:

  • HSV infection in baby or mother
  • CSF pleocytoisis
  • Concerning skin lesions
  • Seizures
  • Abnormal LFTs

Neonatal (28-90 days)

^Acyclovir if:

  • HSV infection in baby or mother
  • CSF pleocytoisis
  • Concerning skin lesions
  • Seizures
  • Abnormal LFTs

Meningitis

MRSA is uncommon in the neonate

Pneumonia (peds)

Newborn

1-3 Month

>3mo - 18 years

Osteomyelitis

  • Empiric treatment: Nafcillin 200mg/kg/day IV div Q6 AND cefotaxime 150mg/kg/day IV div Q8 for >21 days.

UTI (peds)

Neonatal conjunctivitis

Prophylaxis

  • Erythromycin 0.5% ointment x1 or tetracycline 1% or silver nitrate 1% x1 topical (rarely used because of its potential for causing chemical conjunctivitis), applied at birth.

Chemical

  • Watchful waiting

Gonococcal (onset 2-4 days)

  • Cefotaxime 100mg/kg IV or IM OR ceftriaxone 25-50mg/kg IV or IM x1 (not to exceed 125mg)
    • Cefotaxime is preferred because it does not displace bilirubin
    • Disseminated disease should be suspected until CSF is negative
    • Treat mother and partners
    • Irrigate eyes with saline (topical antibiotics are insufficient and unnecessary)

Chlamydia (onset 5-10 days)

  • Erythromycin ophthalmic ointment plus one of the following
  • Disease manifests 5 days post-birth to 2 weeks (late onset)

Herpetic (onset 6-14 days)

  • Acyclovir 20mg/kg IV q8hr x 14-21d
  • Topical antiviral
  • Do not give steroids
  • Full neonatal sepsis evaluation
  • Immediate ophtho consult

Febrile Syndromes/Bloodstream Infections

Pediatric fever of uncertain source (90 days - 36 months)


Septic shock syndromes Bacteremia: S. pneumo, N. meningitidis, H. influenzae (if not immunized) Replete intravascular volume, maximize delivery of oxygen to tissues. Blood cultures. Ceftriaxone 50mg/kg/day IV/IM Q24 or Cefotaxime 150mg/kg/day IV div Q8 until afebrile x24 hours.
Toxic shock syndrome: Staphylococcal (less often associated with deep tissue disease), Streptococcal

Empiric therapy should include clindamycin and beta-lactam until etiology is isolated.

Staphylococcal: Most often associated with toxin-producing organism at a mucosal site, may involved disease at a deeper site. Associated with tampon use, wound infection or burns. 5-15% case fatality rate. Rx: Nafcillin AND clindamycin initially. Substitute cefazolin or vancomycin for nafcillin if MRSA suspected. IVIG 1 g/kg may bind toxins, but should be reserved for life-threatening infections.

Streptococcal: Invasive disease at a deep site is the rule; deep site infection should be sought aggressively and treated. Defined as isolation of GAS, hypotension, renal impairment, coagulopathy, ARDS and soft tissue necrosis. Associated with erysipelas, Necrotizing Fascitis, secondary infection of varicella. Rx: Once streptococcus is identified, change therapy to penicillin or other ß-lactam antibiotic PLUS Clindamycin.

Central line infection Coagulase-negative Staph (CONS), S. aureus, GN-bacilli, Candida spp.

Coagulase-negative Staph (CONS): can try to salvage catheter with 10-14 days of therapy (vancomycin), 80% cure rate for exit site infections, 25% if deeper.

If S. aureus, Gram-Negative bacilli or Candida: always remove the catheter if possible. S. aureus has a 10% exit site cure rate and 0% deeper infection cure rate if catheter left in.

If septic thrombophlebitis, endocarditis, osteomyelitis or repeated positive cultures, ALWAYS remove catheter.

TPN/Intralipids: as above and Malassezia furfur Remove catheter and discontinue antimicrobials if possible. If Candida albicans, treat with Fluconazole 6-12mg/kg/day IV Q24 (if >14 days old) x 28 days OR conventional Amphotericin B 1mg/kg/day IV div Q24. If Staph epidermidis, treat with vancomycin and discontinue intralipids. If M. furfur, treat with conventional Amphotericin B.
Fever and Neutropenia Aerobic GNR, Strep viridans, MRSA

Piperacillin-tazobactam 400mg/kg/day IV div Q6 OR Ceftzidime 150mg/kg/day IV div Q8 OR Meropenem 60mg/kg/day IV div Q8. Consider adding gentamicin if persistently ill-appearing. Consider adding vancomycin if MRSA or coagulase-negative Staph suspected.

Consider adding amphotericin B 1mg/kg/day IV Q24 if persistently febrile >5 days on antibiotics. Consider meropenem alone or addition of metronidazole if typhlitis suspected.

Lyme Disease Borrelia burgdorferi

Early rash (erythema migrans), carditic, facial nerve palsy, meningitis/encephalitis, arthritis.

  • Early localized/disseminated disease: doxycycline 4mg/kg/day PO div BID (if >7 yo) OR amoxicillin 50mg/kg/day PO (max 1.5 g/day) div TID x14-21 days. Alternative erythromycin 30mg/kg/day IV div Q8.
  • Arthritis (no CNS disease): As above x28 days.
  • Bell's Palsy: As above x21-28 days.
  • Neuroborreliosis (CNS): ceftriaxone 75-100mg/kg/day IV Q24 OR penicillin G 300,000 U/kg/day IV div Q4 x14-21 days.
Rocky Mountain Spotted Fever Rickettsia ricketsii

Suspect if fever, rash (95%), petechiae spreading from distal to central. Confirm with antibody titers. Ticks most often in Mid-Atlantic states. Treat empirically and aggressively, can be fatal.

  1. Doxycycline 4mg/kg/day PO div BID x7-10 days (recommend for all age groups).
Ehrlichiosis Ehrlichia chaffensis or phagocytophilum

Suspect if febrile, flu-like illness with rash in April-Sept. Leukopenia and thrombocytopenia common. 80% have positive blood smear (HGE only). Dx HME with PCR. Confirm with DFA. Commonly co-infected with B. burgdorferi.

  1. Doxycycline 4mg/kg/day PO div BID x7 days.


CNS Infections

Meningitis (peds)

Treatment guidelines based on van de Beek et al[9]

Neonates (up to 1 month of age)

MRSA is uncommon in the neonate

> 1 month old

VP shunt infections

  • Empiric therapy: Vancomycin AND Cefotaxime 200 mg/kg/day IV div Q6 OR ceftriaxone 100 mg/kg/day IV div Q12-24
  • Always involved neurosurgery in management
  • Tailor antimicrobial therapy to culture results

Head, Eyes, Ears, Nose & Throat Infections

Mastoiditis, acute

S. pneumo (22%), S. pyogenes (16%), S. aureus (7%), H. flu, P. aeruginosa R/O meningitis. Surgical debridement as indicated. Transition to PO once clinically improved. Ampicillin-sulbactam 300mg/kg/dau IV div Q6 OR cefotaxime 150mg/kg/day div Q8 OR ceftriaxone 50mg/kg/day Q24 +/- nafcillin 200mg/kg/day IV div Q6 OR clindamycin 40mg/kg/day IV div Q6 or vancomycin x21 days.

Sinusitis, acute

  1. Amoxicillin 90mg/kg/day x14-21 days.
  2. Augmentin, cefuroxime or cefdinir if recent antibiotics or chronic sinusitis.

Conjunctivitis

  • Adenovirus (types 3, 7)
    • AKA pink eye. No treatment needed. Highly contagious. Cold artificial tears may help. NEVER treat with steroids except by an ophthalmologist!
  • HSV types 1-2
    • Can be sight-threatening. Refer to ophthalmologist immediately! 30-50% recurrence in 2 years.
    • Trifluridine OR idoxuridine ophthalmic solution 1 drop Q2-3 while awake x7-14 days.
    • Vidarbine ophthalmic ointment Q3 until 1 weeks after healthing.
  • S. pneumo, H. flu
    • Polymyxin/trimethoprim ophthalmic solution 1 drop Q3 OR polymixin.bacitracin/Neosporin ophthalmic solution 1 drop Q3 x7-10 days.

Dacryocystitis

  • Warm compresses and tear duct massage. No antimicrobial therapy usually needed. Oral antimicrobial therapy for more symptomatic infections

Orbital Cellulitis

Periorbital (preseptal) Cellulitis

  1. If known entry site: nafcillin 200mg/kg/day IV div Q6 OR cefazolin 100mg/kg/day IV Q8 x7-10 days. If MRSA suspected, Vancomycin OR clindamycin 40mg/kg/day IV div Q6. Oral antistaphylococcal antibiotics for less severe infections.
  2. Periorbital swelling without cellulitis (often associated with sinusitis): Ceftriaxone 50mg/kg/day IV Q24 OR cefotaxime 150mg/kg/day IV div Q8. ADD clindamycin 40mg/kg/day IV div Q6 for more severe infections of suspicion of MRSA. See 'Head: Sinusitis' for oral therapy options.

Otitis Externa

Otitis Media

Note: If >2 years, afebrile, no otalgia, borderline exam → consider symptomatic treatment or safety net antibiotic prescription (SNAP).

  1. Amoxicillin 80-90mg/kg/day div BID or TID x10 days (<2 years) or x5 days (>2 years).
  2. Augmentin 90mg/kg/day amoxicillin component div BID.
  3. Cefdinir, cefpodoxime, cefprozil, cefuroxime. Azithromycin (up to 40% resistance in PRSP).

Ludwig's Angina

High risk of respiratory tract obstruction due to inflammatory edema.

  1. Penicillin G 200,000 U/kg/day div Q6 AND clindamycin 40mg/kg/day IV vid Q6.
  2. Consider

meropenem, piperacillin-tazobactam OR ceftriaxone if GNR suspected.

Dental abscess

  1. Clindamycin 40mg/kg/day PO/IV/IM div Q6 or Penicillin G 100,000-200,000 U/kg/day IV div Q6.

Gingivostomatitis

  • Acyclovir PO 80mg/kg/day div Q6 x7 days. For severe disease can use Acyclovir 30mg/kg/day IV div Q8.

Bacterial tracheitis

  1. (Vancomycin OR clindamycin 40mg/kg/day div Q6) AND (Cefotaxime 150mg/kg/day div Q8 OR ceftriaxone 50mg/kg/day Q24). Tailor to cultures.
  2. Cefuroxime 100-150mg/kg/day div Q8.

Epiglottitis

Pharyngitis

  • Throat: Culture before treating. GAS uncommon in children <3 years. Treatment decrease rheumatic fever 2.8 to 0.2%. Rx as below also for scarlet fever.
  1. Penicillin V 25-50mg/kg/day PO div TID-QID OR amoxicillin 50-75mg/kg/day div BID-TID x10 days.
  2. Penicillin G Benzathine 600,000 U IM (<27 kg), 1.2 million U (>27 kg) x1.
  3. Erythromycin or clindamycin for PCN-allergic patients.

Respiratory Tract Infections

Pneumonia

Newborn

1-3 Month

>3mo - 18 years

Whooping cough

  1. Erythromycin ethyl succinate 40mg/kg/day PO div QID x14 days (max 2000mg/day). Note: Do not use erythromycin base, which causes excessive GI symptoms.
  2. Azithromycin (<6 months): 10mg/kg once daily x5 days (max 500mg). Note: Preferred agent for patients <1 month.

Cardiovascular Infections

Endocarditis

Prophylaxis indications Prosthetic cardiac valve or prosthetic material used for cardiac valve repair.

Previous infectious endocarditis.

Congenital heart disease (CHD) - except for the conditions listed below, antibiotic prophylaxis is no longer recommended for any other form of CHD.

  • Unrepaired cyanotic CHD, including palliative shunts and conduits.
  • Completely repaired CHD with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure.
  • Repaired CHD with residual defects at the site or adjacent to the site or a prosthetic patch or prosthetic device (which inhibit endothelialization).

Cardiac transplantation recipients who develop cardiac valvulopathy.

Prophylaxis for oral, dental, respiratory tract or high risk patients with chronic GI/GU infections

  1. Amoxicillin 50mg/kg PO x1 OR Ampicillin 50mg/kg IV x1, 30-60 minutes prior to the procedure.
  2. Allergic patients: Clindamycin 20mg/kg PO/IV x1 OR cephalexin 50mg/kg PO x1 OR azithromycin 15mg/kg PO x1.

Empiric therapy, native valves: S. viridans, Enterococci, Staphylococci

By definition includes multiple positive blood cultures, new murmur of valvular insufficiency, emboli and echo evidence of vegetations. Send cultures and target therapy based on results. Vancomycin and Gentamicin pending culture results.

Gastroenterologic Infections

Diarrhea

Initial Workup: If blood diarrhea or >6 stools/day and febrile then consider stool cultures, fecal leukocytes, electrolytes.

Isolation: Contact precautions for diapered or incontinent children.

C. difficile

Suspect if blood diarrhea, cramping develop with recent antibiotic exposure.

  1. Metronidazole 30mg/kg/day PO/IV div QID x10 days.
  2. Vancomycin 40mg/kg/day PO;div QID x10 days ONLY for Metronidazole failures.
C. jejuni

Suspect if prominent abdominal pain. Young infants may only have bloody diarrhea. Can have immunoreactive complications such as AIDP, reactive arthritis, Reiter syndrome or erythema nodosum.

  1. Erythromycin 40mg/kg/day PO div QID x5 days. Shortens duration of illness and prevents relapse if given early.

E. coli O157:H7

(Enterotoxin producing, ETEC)

Suspect if bloody diarrhea, >6 unformed stools/day and afebrile. Causes 36% of bloody diarrhea. Consider CBC and blood smear. If no hemolysis, azotemia or thrombocytopenia after 3 days of illness, risk of developing HUS is low. Antimicrobial therapy may precipitate an adverse reaction.
Salmonella

May cause asymptomatic disease, gastroenteritis, bacteremia, osteomyelitis or meningitis. Exposures to lizards and other reptiles may result in unusual species of Salmonella.

  1. Antimicrobial therapy increases duration of illness in most carriers.
  2. Therapy recommended if invasive or focal disease, if <3 months old, chronic GI disease, oncology patients, hemoglobinopathies, or HIV+. May treat with amoxicillin or TMP-SMX; Ceftriaxone for neonates (not receiving calcium containing fluids) or septic clinical state.
Shigella

Suspect if fever, cramps, tenesmus, abdominal pain. Complications include seizures, bacteremia, Reiter Syndrome, HUS (S. dystenteriae;type 1), toxic megacolon and toxic encephalopathy (ekiri syndrome).

  1. Cefixime 8mg/kg/day PO div BID or TMP-SMX 8mg/kg/day TMP PO div TID x5-7 days. Illness usually self-limited (48-72 hours), but treatment is always indicated to decrease duration of shedding, which is important for public health measures.
Yersinia enterocolitica
Causes mesenteric adenitis, mimics appendicitis. Predisposed by iron overload states (chronic transfusions). Antimicrobial therapies not indicated in normal hosts.
Necrotizing Enterocolitis (NEC) Multifactorial disease, including bacterial invasion (debated). E. coli, Klebsiella, Pseudomonas, Clostridial sp., S. aureus, B. fragilis.

Bacteremia in 30-50% of cases. Definitive antimicrobial therapy based on culture results. B. fragilis invades gut after several days of age.

  1. Ampicillin AND gentamicin x10 or more days

Consider adding cefotaxime if CNS involvement cannot be excluded. Consider replacing ampicillin with vancomycin if MRSA/CONS. Consider adding clindamycin if perforation cannot be excluded.

Peritonitis (bowel perforation or appendicitis)
Enteric GNR, Bacteroides sp., Enterococcus sp.
  1. Meropenem 60mg/kg/day IV div Q8 OR piperacillin-tazobactam 400mg/kg/day IV div Q6 x7-10 days.
  2. Ampicillin 150mg/kg/day IV div Q8 AND gentamicin (dose per age) IV div Q8 AND clindamycin 40mg/kg/day IV Q6 OR metronidazole 30mg/kg/day IV div Q6] x7-10 days.
Peritonitis (peritoneal dialysis)
Staphylococci, GNs, yeast
Antibiotic added to dialysate in concentrations approximating those attained in serum for systemic disease gentamicin 8mg/L, Vancomycin 50mg/L).

Genitourinary Infections

Pyelonephritis

Inpatient: Ceftriaxone 50mg/kg/day IV/IM Q24 OR gentamicin (age based dosing) OR [[TMP/SMX] 8mg/kg/day IV div BID x14 days. Treat IV until defervesces and clinically improved, then transition to PO.

Outpatient: TMP-SMX OR cefixime OR ciprofloxacin (in adolescents); see doses under UTI

UTI

Inpatient: >2 months: cefotaxime or ceftriaxone until taking PO, well appearing → transition to outpatient therapy.

Outpatient: (Infants and Children): TMP-SMX 6-10mg/kg/day TMP component div BID OR cefixime 16mg/kg/day x1 day, then 8mg/kg/day Q24 (max 400mg/dose) OR cephalexin 25mg/kg/dose QID (max 1000mg/dose) x7-14 days. Alternatives: nitrofurantoin, ciprofloxacin, ceftriaxone.

Skin & Soft Tissue Infections

Skin abscess

  • OSSA/MSSA - Cephalexin 50-75mg/kg/day PO div TID OR Augmentin 80-90mg/kg/day PO div BID x5-7 days. I&D when indicated.
  • If MRSA prevalent or if recurrent abscess, send specimen for culture and sensitivity. Treat with clindamycin 40mg/kg/day IV div Q6 or TMP-SMX 5mg/kg/dose TMP Q6-8. If toxic-appearing, use vancomycin.

Cellulitis

  • Start IV: Clindamycin 40mg/kg/day IV div Q6 if high community incidence of MRSA. May use nafcillin 200mg/kg/day IV div Q6 OR cefazolin 100mg/kg/day IV div Q8 if low incidence of MRSA. Transition to PO when stable. If no improvement, change to vancomycin (dose by age).
  • PO: Cephalexin 50-75mg/kg/day divided TID OR dicloxacillin 50mg/kg/day PO div Q6. Total duration of treatment 7-10 days.

Erysipelas

Impetigo

Omphalitis/Funisitis

  • Funisitis (local infection of cord): cord care, topical antimicrobials.

Paronychia

  • Local wound care and I&D unless signs of spreading infection, then consider Augmentin or clindamycin.

Scabies

  1. Topical 5% permethrin cream, apply to neck down, wash off in 8-14 hours.
  2. Topical Lindane 1%- Avoid unless treatment failure to permethrin due to risk of neurotoxicity. Many contraindications/precautions!

Staphylococcal scalded skin syndrome

  1. Nafcillin 200mg/kg/day IV div Q6 OR Cefazolin IV x5-7 days. Consider vancomycin.

Avoid TMP-SMX.

Tinea corporis

  • May use one of many topical antifungal agents: Terbinafine 1% cream or gel BID to affected areas; clotrimazole 1% cream, lotion or solution; others include Econazole, Sulconazole, Oxiconazole, Naftifine, Cicloprox, Ketoconazole, Sertaconazle, Moconazole and Tolnaftate. Treat for 14 days. Keep affected areas dry.

Tinea capitis

  • Griseofulvin Microsize 10-20mg/kg/day div Q12-24 (max 1000mg/day) OR Griseofulvin Ultramicrosize >2 years 5-10mg/kg/day div Q12-24 x6 weeks] AND Selenium sulfide shampoo twice weekly x1 week as directed.

Necrotizing Fasciitis

  1. Prompt surgical debridement and cultures. Send for cultures and sensitivities.
  2. Treat with clindamycin AND Zosyn OR cefotaxime. For proven streptococcal disease, penicillin and clindamycin suffice.


Animal bites Rabies prone: BATS, feral cats, raccoon, skunk, foxes, coyotes, most carnivores, woodchucks and livestock in certain areas

Treat all bat and feral cat exposures with both HRIG and Rabies vaccine as below. Otherwise, treat with vaccine and contact public health officials or infection control for advice on whether to treat with HRIG. Monitor animal for 10 days.

  1. Rabies vaccine 1 mL;IM into deltoid days 0, 3, 7, 14 and 28.
  2. HRIG 20 IU/kg around wound and begin vaccination series with HDCV or;RVA vaccine days 0, 3, 7, 14 and 28.
  3. Consider treating with Augmentin as below.
Non Rabies-prone: Rodents, rabbits, hares, squirrels, hamsters, guinea pigs, gerbils, rats, chipmunks and mice usually do not require anti-rabies therapy. Consult public health officials with concerns. Check tetanus status. Consider Augmentin as below.
Cat: Pasteurella multocida, S. aureus
  1. Augmentin 45mg/kg/day div Q8-12 x5-7 days. For penicillin allergic patients, Pasteurella is covered by doxycycline or ciprofloxacin. Add another drug for Strep;or Staph sp.
  2. Rabies: See above if feral cat. Check tetanus status.
Dog: Pasteurella multocida, S. aureu's, Bacteroides, Fusobacterium, Capnophaga
  1. Augmentin 45mg/kg/day PO div Q8-12 x5-7 days
  2. Rabies: see above. Check tetanus status.
Human: Strep viridans;(100%), Staph epinephrine (53%), Cornybacterium (41%), S. aureus (29%), Eikenella, Bacteroides, Peptostrep

High rates of infection. Do not close open wounds!

  1. Early (no signs of infection): Augmentin 45mg/kg/day PO div Q8-12 x5-7 days.
  2. Late (signs of infection): Ampicillin-sulbactam IV. Can use clindamycin AND ampicillin.
  3. Check tetanus status.
Rat or pig (polymicrobial, Sprillum minus, Streptobacillus)
  1. Augmentin 45mg/kg/day PO div Q8-12 x5-7 days
  2. Rabies: see above. Check tetanus status.
Lymphadenitis
Localized infection: GAS, S. aureus (MRSA)...less likely anaerobes, M. Tb (scrofula), Toxoplasmosis, Tularemia, Sporotrichosis,;atypical mycobacterial (consider the latter if nonresponsive to antimicrobials)

MSSA: Augmentin 90mg/kg/day PO div BID OR Cephalexin 100mg/kg/day PO div QID x10 days. If IV needed, cefazolin 100mg/kg/day IV div Q8.

MRSA: Clindamycin OR TMP-SMX OR linezolid OR vancomycin (age based dosing) x7-10 days total.

Cat-scratch disease: Bartonella henslae

Lymphadenitis common in axillary/epitrochlear nodes (46%), neck (26%), inguinal (17%). Treat for immunocompromised host of signs of systemic illness;(HSM).

  1. Azithromycin 10mg/kg/day PO Q24 x5 days.

May also use Bactrim, rifampin and ciprofloxacin. Duration of therapy is uncertain.

Orthopedic Infections

Osteomyelitis

Risk Factor Likely Organism Initial Empiric Antibiotic Therapy'
Elderly, hematogenous spread MRSA, MSSA, gram neg Vancomycin 1gm + (Piperacillin/Tazobactam 3.375 grams OR imipenem 500mg)
Sickle Cell Disease Salmonella, gram-negative bacteria Ceftriaxone 50mg/kg IV once daily OR Cefotaxime 50mg/kg IV three times daily, PLUS
  • Vancomycin 15mg/kg IV four times daily OR
  • Clindamycin 10mg/kg IV PO four times daily OR
  • Nafcillin 50 mg/kg IV four times daily to cover K. Kingae (common in daycare population)
DM or vascular insufficiency Polymicrobial: Staph, strep, coliforms, anaerobes Vancomycin 1gm + (Piperacillin/Tazobactam 3.375 grams OR imipenem 500mg)
IV drug user MRSA, MSSA, pseudomonas Vancomycin 1gm 
Newborn MRSA, MSSA, GBS, Gram Negative Vancomycin 15mg/kg load, then reduce dose, AND ceftazidime 30mg/kg IV q12 h
Children MRSA, MSSA Vancomycin 10mg/kg q6 h AND ceftazidime 50mg/kg q8hr
Postoperative (ortho) MRSA, MSSA Vancomycin 1gm
Human bite Strep, anaerobes, HACEK organism Piperacillin/Tazobactam 3.375gm OR imipenem 500mg
Animal bites Pasteurella, Eikenella, HACEK organism Piperacillin/Tazobactam 3.375gm OR imipenem 500mg
Foot puncture wound Pseudomonas Anti-pseudomonal, staph coverage

Septic Arthritis

See Also

Antibiotics by diagnosis

For antibiotics by organism see Microbiology (Main)

References

  1. https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1
  2. Sanford Guide to Antimicrobial Therapy 2014
  3. Sanford Guide to Antimicrobial Therapy 2014
  4. Sanford Guide to Antimicrobial Therapy 2014
  5. Sanford Guide to Antimicrobial Therapy 2014
  6. Sanford Guide to Antimicrobial Therapy 2014
  7. Sanford Guide to Antimicrobial Therapy 2014
  8. Sanford Guide to Antimicrobial Therapy 2014
  9. van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702
  10. https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1
  11. Sanford Guide to Antimicrobial Therapy 2014
  12. Sanford Guide to Antimicrobial Therapy 2014
  13. Sanford Guide to Antimicrobial Therapy 2014
  14. Sanford Guide to Antimicrobial Therapy 2014
  15. Sanford Guide to Antimicrobial Therapy 2014
  16. Sanford Guide to Antimicrobial Therapy 2014
  17. Sanford Guide to Antimicrobial Therapy 2014